ABSTRACT
PURPOSE: Changes in the entire health care system during COVID-19 epidemic have affected the management of patients with head and neck cancer and posed several clinical challenges for ENT surgeons. Therefore, the present study aimed to investigate the effect of COVID-19 on the stage and the type of surgical treatments used in laryngeal cancer (including total laryngectomy, supracricoid partial laryngectomy (SCPL) and transoral laser microsurgery (TLM)) and also to compare the results of April 2020 to April 2021 with the previous year. MATERIALS AND METHODS: This cross-sectional study was performed on all patients with a diagnosis of laryngeal cancer who underwent surgery in the tertiary care center from April 2020 to April 2021 and the year before the pandemic in the same time. Demographic, cancer stage, and treatment data of all patients were recorded and analysis in two groups. RESULTS: Patients referred at the time of the virus outbreak; 111 were male and 5 were female, and in the group of patients referred before COVID-19, 90 were male and 12 were female. The type of surgical treatment of laryngeal cancer, mean time elapsed from sampling to surgery, stage of disease and mean tumor volume was statistically significant differences in patients before and during the outbreak. CONCLUSION: Patients who referred for diagnosis and treatment at the time of COVID-19 outbreak had more advanced stages of the disease and also the tumor volume was higher in them than patients who had referred before the outbreak. It is necessary to provide new solutions, education and treatment management for patients with laryngeal cancer in such pandemics.
Subject(s)
COVID-19 , Laryngeal Neoplasms , Laser Therapy , COVID-19/epidemiology , Cross-Sectional Studies , Female , Humans , Laryngeal Neoplasms/epidemiology , Laryngeal Neoplasms/etiology , Laryngeal Neoplasms/surgery , Laryngectomy/methods , Laser Therapy/methods , Male , Pandemics , Retrospective Studies , SARS-CoV-2 , Treatment OutcomeSubject(s)
Beclomethasone/therapeutic use , COVID-19/complications , HIV Infections/complications , Laryngectomy/methods , Neck Dissection/methods , Olfaction Disorders/etiology , Parotid Neoplasms/diagnostic imaging , Administration, Intranasal , Anti-HIV Agents/adverse effects , Anti-HIV Agents/therapeutic use , Beclomethasone/administration & dosage , Beclomethasone/adverse effects , Drug Interactions , Humans , Incidental Findings , Positron-Emission Tomography , Salvage TherapyABSTRACT
This review explores the changes to practice associated with COVID-19 for providers treating patients with head and neck cancer and laryngeal pathology. The aim of the review is to highlight some of the challenges and considerations associated with treating this patient population during the pandemic. Additionally, it seeks to discuss some of the areas of concern related to ramping up clinical volume.
Subject(s)
Coronavirus Infections/prevention & control , Elective Surgical Procedures/statistics & numerical data , Head and Neck Neoplasms/surgery , Infection Control/methods , Laryngectomy/methods , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Telemedicine/statistics & numerical data , Adult , Aged , COVID-19 , Coronavirus Infections/epidemiology , Elective Surgical Procedures/methods , Female , Head and Neck Neoplasms/diagnosis , Humans , Laryngectomy/adverse effects , Male , Middle Aged , Occupational Health/statistics & numerical data , Pandemics/statistics & numerical data , Patient Safety/statistics & numerical data , Personal Protective Equipment/statistics & numerical data , Pneumonia, Viral/epidemiology , Safety Management , Telemedicine/methods , United StatesABSTRACT
With the COVID-19 pandemic, there has been significant changes and challenges in the management of oncology patients. One of the major strategies to reduce transmission of the virus between patients and healthcare workers is deferral of follow-up visits. However, deferral may not be possible in total laryngectomy patients. Urgent procedures may be necessary to prevent complications related to ill-fitting tracheoesophageal puncture (TEP) voice prostheses, such as aspiration or loss of voicing. In this paper, we describe the Princess Margaret Cancer Center's approach to managing this unique patient population.
Subject(s)
Coronavirus Infections/prevention & control , Infection Control/organization & administration , Laryngeal Neoplasms/surgery , Laryngectomy/statistics & numerical data , Outcome Assessment, Health Care , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , COVID-19 , Coronavirus Infections/epidemiology , Cross Infection/prevention & control , Elective Surgical Procedures/methods , Elective Surgical Procedures/statistics & numerical data , Female , Humans , Laryngeal Neoplasms/diagnosis , Laryngectomy/methods , Larynx, Artificial , Male , Ontario , Pandemics/statistics & numerical data , Pneumonia, Viral/epidemiology , Prosthesis Implantation/methods , Prosthesis Implantation/statistics & numerical data , Risk AssessmentABSTRACT
OBJECTIVE: To report our experience of diagnosis, investigation and management in patients who had undergone laryngectomy secondary to previous squamous cell carcinoma, who were subsequently infected with severe acute respiratory syndrome coronavirus-2 during the coronavirus disease 2019 pandemic. CASE REPORTS: Four post-laryngectomy patients with laboratory-proven severe acute respiratory syndrome coronavirus-2 infection were admitted to our institution from 1 March to 1 May 2020. All patients displayed symptoms of coronavirus disease 2019 and underwent investigations, including swab and serum sampling, and chest X-ray where indicated. All were managed conservatively on dedicated coronavirus disease 2019 wards and were discharged without the requirement of higher level care. CONCLUSION: It is hypothesised that laryngectomy may offer a protective effect against severe or critical disease in severe acute respiratory syndrome coronavirus-2 infection. We hope sharing our experience will aid all practitioners in the management of this, often intimidating, cohort of patients.
Subject(s)
Carcinoma, Squamous Cell/surgery , Coronavirus Infections/diagnosis , Laryngeal Neoplasms/pathology , Laryngectomy/adverse effects , Pneumonia, Viral/diagnosis , Aged , Betacoronavirus/isolation & purification , COVID-19 , Conservative Treatment/methods , Coronavirus Infections/epidemiology , Coronavirus Infections/therapy , Coronavirus Infections/virology , Female , Humans , Laryngectomy/methods , Male , Middle Aged , Neoplasm Staging , Pandemics , Pneumonia, Viral/epidemiology , Pneumonia, Viral/therapy , Pneumonia, Viral/virology , Postoperative Complications/virology , SARS-CoV-2 , Treatment OutcomeSubject(s)
COVID-19/prevention & control , Disease Transmission, Infectious/prevention & control , Laryngectomy/methods , Pharynx/surgery , Surgical Stapling/methods , Adult , Aged , Aged, 80 and over , COVID-19/transmission , Female , Humans , Male , Middle Aged , Occupational Exposure/prevention & control , SARS-CoV-2ABSTRACT
The coronavirus disease-2019 (COVID-19) pandemic has rapidly spread across the world, placing unprecedented strain on the health care system. Health care resources including hospital beds, ICUs, as well as personal protective equipment are becoming increasingly rationed and scare commodities. In this environment, the laryngectomee (patient having previously undergone a total laryngectomy) continues to represent a unique patient with unique needs. Given their surgically altered airway, they pose a challenge to manage for the otolaryngologist within the current COVID-19 pandemic. In this brief report, we present special considerations and best practice recommendations in the management of total laryngectomy patients. We also discuss recommendations for laryngectomy patients and minimizing community exposures.
Subject(s)
Coronavirus Infections/epidemiology , Disease Management , Laryngectomy/methods , Pandemics/prevention & control , Patient Safety , Pneumonia, Viral/epidemiology , COVID-19 , Communicable Disease Control/methods , Coronavirus Infections/prevention & control , Female , Humans , Male , Patient Care/methods , Pneumonia, Viral/prevention & control , Risk AssessmentABSTRACT
Head and neck cancer patients with tracheostomies and laryngectomies, as well as their healthcare providers, face unique challenges in the context of the current COVID-19 pandemic. This document consolidates best available evidence to date and presents recommendations to minimize the risks of aerosolization and SARS-CoV-2 exposures in both the inpatient and outpatient settings. The cornerstones of these recommendations include the use of closed-circuit ventilation whenever possible, cuffed tracheostomy tubes, judicious use of heat moisture exchange units, appropriate personal protective equipment for providers and patients, meticulous hand hygiene, and minimal manipulation of tracheostomy tubes.